Biden administration will work with world democracy to coordinate multilateral efforts to overcome pandemics, and Biden said he hoped to announce progress in these efforts on the G-7 Summit to be held by the UK in June
The US will work with Covax facilities supported by WHO and other partners for a fair distribution of around 80 million Covid-19 vaccines from stocks in line with public health science and data from all over the world, President Joe Biden said.
Biden administration will work with world democracy to coordinate multilateral efforts to overcome a pandemic, and Biden said he hoped to announce progress in this effort to the G-7 Summit which will be held by the UK in June.
Biden announced on Monday that the US would share 20 million doses from the stock surplus of the Pfizer, Modern and Johnson Johnson vaccine at the end of June. It will be an addition to previous US commitments to share 60 million doses of astrazeneca vaccines with countries around the world.
This is the first time the US said it would distribute three vaccines authorized for use in this country, and his steps came from Biden’s administrative beliefs that it would take enough dose delivery to protect everyone in the US in June in June.
The US is believed to currently have around 10 million doses of astrazeneca vaccine, which has not been approved for use in this country, and inventory is expected to swell to 60 million doses at the end of June. The Biden government said this dose would be distributed only after the vaccine cleared the safety review by Food and Drug Administration (FDA).
Describing the procedure that will be followed for the distribution of surplus vaccines, white home facts sheets say, “The United States will work with Covax and other partners to ensure this vaccine is conveyed in a fair way and participate in science and follow the knowledge of public health data.”
It was added, “In the coming weeks, working with the world democracy of the government of Biden-Harris will coordinate multilateral efforts to end the pandemic. We hope to be advanced on the G7 summit in June.”
The fact sheet says the US will send 80 million doses to countries against the “at the end of June”, and that the contribution of the excess supply of America will continue “because the supply was sent to us”.
The White House repeated what Biden regarding the distribution of vaccines that were not related to securing assistance from other countries, a real reference to similar efforts by China and Russia.
“Just as in the Second World War, America is a warehouse of democracy, in battle against the Covid-19 pandemic, our nation will become a vaccine warehouse for the whole world. We will share this vaccine in the service ending the pandemic everywhere. And we will not use Our vaccine is to secure assistance from other countries, “said Biden.
The recent US government said he was looking at the combined production of Johnson & Johnson vaccine in India and ways to help Indian manufacturers such as the Indian Serum Institute (SII) to increase production to meet vaccine needs throughout the world.
The US Administration works on the list of Indian government raw materials and other inventory inventories that are needed to produce vaccines but American officials have warned this will not be an easy task because of disruption to the global supply chain.
The US has also transferred sufficient AstraZeneca inventory from existing orders to produce more than 20 million doses in India.
The US currently works with the private sector and other partners to expand the creation and distribution of global vaccines and production of vital raw materials. The US International Development Finance Corporation has launched a global vaccine initiative that targets investment in various regions of the world to address short-term requirements and secondary efforts to ensure better health preparedness.
This includes a quad vaccine partnership to supply one billion doses of Covid-19 vaccine, including Johnson & Johnson vaccine, at the end of 2022.
The Biden government has also supported the proposal to be debated by India and South Africa in the World Trade Organization (WTO) last year to release intellectual property protection for the Covid-19 vaccine, although officials have warned that this will involve negotiations that can take months , , if it’s not for years. The European Union, however, has not shown a tendency to support this step.